Medline C-Section Surgical Kits Recalled Over Adhesive Residue: Health Canada

Health Canada has posted a Type II recall correction notice for Medline Sterile Surgical Kits that contain the Medline C-Section Drape w/Incise. The notice, published on October 1, 2026 under identification number RA-82716, lists a recall date of September 16, 2026. The audience is healthcare providers, not the general public.

The notice was issued after reports that the surgical drapes were difficult to remove from patients and left adhesive residue on their skin. The manufacturer is Medline Industries, LP, based in Northfield, Illinois.

Quick Facts

• Product: Medline Sterile Surgical Kits containing Medline C-Section Drape w/Incise
• Company: Medline Industries, LP
• Recall number: RA-82716
• Recall class: Type II
• Recall date: September 16, 2026
• Lots affected: All lots
• Issue: Medical devices – Performance

The Reason Behind the Recall

The issue is classed as a performance problem with the medical device. Health Canada’s notice says the drapes can be hard to take off a patient and can leave adhesive behind on the skin.

Where this happens, patients may have temporary redness, irritation or a superficial skin injury during removal. The notice describes these effects as temporary, and it does not report any longer-term harm.

Health Canada has not published the number of complaints behind the notice, and it does not say how many kits were distributed.

Products Affected by This Recall

The recall covers a long list of Medline kit configurations that include the C-Section Drape w/Incise. Many are named for particular hospitals or health authorities, and several carry French-language names. The notice lists every lot of each configuration as affected, so a lot number cannot be used to rule a kit out.

Examples from the notice include the following, each with its model or catalogue number:

• NHS-C-Section SCG (DYNJ40573A)
• C Section TEGH-LF (DYNJ46729)
• Ensemble A Cesarienne-LF (DYNJ57105A)
• C – Section Pack (several catalogue numbers, including DYNJ41812D, DYNJ41672B, DYNJ41766C and DYNJ40031B)
• Labor And Delivery Tray (DYNJ41696D and DYNJ27206D)
• C Section Tray (DYNJS0612)
• Cesarean Section-LF (DYNJ88822A and DYNJ88822)
• C-Section TBRHSC-LF (DYNJ41938B)

The full list has 39 entries. It also includes items such as P2021013P Cesarienne – CISSS C (DYNJT3919), C-Section PCH- LF (DYNJ81281), SHN-C-Section-LF (DYNJ46866B) and C Section With Fields (DYNJ87723). The entry for C Section BWH-LF has no catalogue number in the notice. Anyone checking inventory should compare against the complete table on the Health Canada page.

Who Should Be Concerned

This notice is aimed at healthcare settings that stock or use Medline surgical kits for cesarean sections and labour and delivery. Hospital supply managers, operating room staff and infection prevention teams are the people most likely to handle the affected kits.

Patients who have had a cesarean delivery are not being asked to take any action. The listed effects are temporary skin reactions that happen when the drape is removed. A patient with questions about skin irritation after surgery should speak with their care team.

Steps Healthcare Customers Should Take

Health Canada’s guidance for this recall is short. Customers using these devices should follow the mitigation strategies set out in the manufacturer’s notice. The Health Canada page does not reproduce those strategies, so facilities should look at the notice they received from Medline directly.

• Check inventory against the model and catalogue numbers in the Health Canada notice.
• Read and follow the mitigation strategies in the manufacturer’s correction notice.
• Share the information with clinical staff who handle drape removal.
• Contact the manufacturer if you need additional information.

The notice does not mention a refund, replacement or return process. Health Canada’s only stated action is to contact the manufacturer for more information, and the page does not give contact details for Medline.

Regulatory Response

Health Canada published the notice as a Health product recall under the Medical devices category, in the General hospital and personal use and General and plastic surgery subjects. It classed the recall as Type II. The agency’s page ties that classification to the reported skin effects and gives no wider public warning.

As of the October 1, 2026 posting, the notice identifies Medline Industries, LP as the company responsible for the affected products. Healthcare customers who want more detail on the issue or the mitigation steps are directed to the manufacturer.